Osho Asishana A, Castleberry Anthony W, Snyder Laurie D, Palmer Scott M, Ganapathi Asvin M, Hirji Sameer A, Lin Shu S, Davis R Duane, Hartwig Matthew G
School of Medicine, Duke University Medical Center, Durham, North Carolina.
Department of Surgery, Duke University Medical Center, Durham, North Carolina.
Ann Thorac Surg. 2014 Dec;98(6):1914-20; discussion 1920-1. doi: 10.1016/j.athoracsur.2014.06.036. Epub 2014 Oct 17.
Rates of repeat lung transplantation have increased since implementation of the lung allocation score (LAS). The purpose of this study is to compare survival between repeat (ReTx) and primary (LTx) lung transplant recipients in the LAS era.
We extracted data from 9,270 LTx and 456 ReTx recipients since LAS implementation, from the United Network for Organ Sharing registry. Propensity scoring was used to match ReTx and LTx recipients. Kaplan-Meier analysis compared survival between LTx and ReTx groups, with and without stratification based on time between first and second transplant. Multivariable Cox models estimated predictors of survival in lung recipients.
Comparing all ReTx to LTx demonstrates a survival advantage for LTx that is diminished with propensity score matching (p = 0.174). Considering LTx against ReTx greater than 90 days after the initial procedure, there are similar survival results (p < 0.067). In contrast, ReTx within 90 days was associated with a survival disadvantage that persisted despite matching (p = 0.011). In ReTx populations, factors conferring worse outcomes include intensive care unit admission, unilateral transplantation, poor functional status, and primary graft dysfunction as the indication for retransplantation (p < 0.05).
Late lung retransplantation appears to be as beneficial as primary transplantation in propensity-matched patients. However, survival is severely diminished in those retransplanted less than 90 days after primary transplantation. The utility of early retransplantation needs to be carefully weighed in light of risks.
自实施肺分配评分(LAS)以来,再次肺移植的发生率有所增加。本研究的目的是比较LAS时代再次(ReTx)和初次(LTx)肺移植受者之间的生存率。
我们从器官共享联合网络登记处提取了自LAS实施以来9270例LTx受者和456例ReTx受者的数据。采用倾向评分法对ReTx和LTx受者进行匹配。Kaplan-Meier分析比较了LTx组和ReTx组之间的生存率,以及根据首次和第二次移植之间的时间进行分层和未分层的情况。多变量Cox模型估计了肺移植受者生存的预测因素。
将所有ReTx与LTx进行比较,显示LTx具有生存优势,但倾向评分匹配后这种优势减弱(p = 0.174)。将LTx与初次手术后90天以上的ReTx进行比较,生存结果相似(p < 0.067)。相比之下,90天内的ReTx与生存劣势相关,尽管进行了匹配,这种劣势仍然存在(p = 0.011)。在ReTx人群中,导致预后较差的因素包括入住重症监护病房、单侧移植、功能状态差以及作为再次移植指征的原发性移植物功能障碍(p < 0.05)。
在倾向评分匹配的患者中,晚期肺再次移植似乎与初次移植一样有益。然而,在初次移植后不到90天进行再次移植的患者中,生存率会严重降低。鉴于风险,需要仔细权衡早期再次移植的效用。